← Leaderboards
Anne Rietz
Kovina Therapeutics Inc.
$2,330,674
Attributed
$2,330,674
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2022–24$2M$1.5M$1M$500K$0
'22
'23
'24
Funding mix
By agency
NIH$2,330,674 · 2
By mechanism
R44$1,909,685 · 1
R42$420,989 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Academia”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Alaina J Harkness · Current Innovation, Nfp$13,724,091
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,536,813
- Michael George Natchus · Emory University$10,548,554
- Raymond Paul Goodrich · Colorado State University$4,057,902
Research focus
AcademiaComplexAlgorithmsAdductAffinityClinical TrialsBindingBiochemicalBiotechnologyBusinessesCancer CellCancer Cell LineCanis FamiliarisCareerCell Culture TechniquesCell GrowthCell ProliferationCellsCell SurvivalCellular TargetingCervicalChemistryChronic InfectionCoupled
Grant awards (3)
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer$1,000,028
R44 · FY2024 · CA · contact PI
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer$909,657
R44 · FY2023 · CA · contact PI
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer$420,989
R42 · FY2022 · CA · contact PI